We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Health Outcomes in Rheumatoid Arthritis (HORA)

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00346411
First Posted: June 29, 2006
Last Update Posted: October 5, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Johns Hopkins University
June 28, 2006
June 29, 2006
October 5, 2017
September 1, 2005
December 12, 2011   (Final data collection date for primary outcome measure)
Not Provided
Not Provided
Complete list of historical versions of study NCT00346411 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Health Outcomes in Rheumatoid Arthritis
Health Outcomes in Rheumatoid Arthritis
This research is being done to help us learn about how different factors related to treatment affect rheumatoid arthritis (RA). This is not a treatment study. We will follow the patient for one year as he or she receives usual treatment from his or her rheumatologist. Up to 360 adults with RA may join this study.
Not Provided
Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample
Individuals diagnosed with rheumatoid arthritis and receiving treatment for this condition from a rheumatologist
Rheumatoid Arthritis
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
164
December 12, 2011
December 12, 2011   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Males and females age 19 or older
  • Current active, adult-onset rheumatoid arthritis who meet American College of Rheumatology (ACR) criteria for RA and have: (ACR functional class I-III), defined as:
  • 3 or more swollen or tender joints and
  • Morning stiffness of 45min or longer
  • OR judged by their rheumatologist to have active disease
  • No evidence of other inflammatory diseases (e.g., Crohn's, IBS)
  • Functional class I, II or III

Exclusion Criteria:

  • Individuals with significant cardiovascular disease (CHF, stroke, MI)
  • Unwilling to have medications monitored and/or comply with protocol
  • Not fluent in English
  • Planning to move from area within next year or change health insurance (which would preclude ongoing care by a Johns Hopkins rheumatologist)
  • Enrolled in study evaluating efficacy of new or existing RA medications
Sexes Eligible for Study: All
19 Years and older   (Adult, Senior)
No
Contact information is only displayed when the study is recruiting subjects
United States
 
 
NCT00346411
NA_00001359
Not Provided
Not Provided
Not Provided
Johns Hopkins University
Johns Hopkins University
Not Provided
Principal Investigator: Susan Bartlett, PhD Johns Hopkins School of Medicine
Principal Investigator: Cynthia S Rand, PhD Johns Hopkins University
Johns Hopkins University
October 2017